Search
for
Sort by
Research 511–540 of 1000+
- Vitamin D and the Skin: A Review for Dermatologists
- Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels
- Effective holistic characterization of small molecule effects using heterogeneous biological networks
- Secondary Metabolites with Antifungal Activities from Mangrove Derived Fungus Monascus purpureus WMD2424
- The Roles of Non-coding RNA in the Development and Regeneration of Hair Follicles: Current Status and Further Perspectives
- COVID-19 in Africa: an ovarian victory?
- Age-related changes in endogenous glucocorticoids, gonadal steroids, endocannabinoids and their ratios in plasma and hair from the male C57BL/6 mice
- Biomarkers of selenium status in dogs
- Expression Profiles of Tyrosine Kinases in Cultured Follicular Papilla Cells Versus Dermal Fibroblasts
- Exploring the application of dietary antioxidant index for disease risk assessment: a comprehensive review
- The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
- Cell Membrane-Camouflaged Nanoparticles Mediated Nucleic Acids Delivery
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- Extracellular vesicles in age-related diseases: disease pathogenesis, intervention, and biomarker
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
- Design and Validation of a Sensitive Multisteroid LC-MS/MS Assay for the Routine Clinical Use: One-Step Sample Preparation with Phospholipid Removal and Comparison to Immunoassays
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- IGFBP5 Promotes Neuronal Apoptosis in a 6-OHDA-Toxicant Model of Parkinson’s Disease by Inhibiting the Sonic Hedgehog Signaling Pathway
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- New Insights into Testosterone Biosynthesis: Novel Observations from HSD17B3 Deficient Mice
- Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants
- PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands
- Ultrasound Depolymerization and Characterization of Poly- and Oligosaccharides from the Red Alga Solieria chordalis (C. Agardh) J. Agardh 1842
- Regulation of cashmere fineness traits by noncoding RNA in Jiangnan cashmere goats
- A quantitative ultra-performance liquid chromatography high-resolution mass spectrometry analysis of steroids from human scalp hair
- In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole
- Antiandrogens as Therapies for COVID-19: A Systematic Review